This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Pedro Diz Dios, MD, DDS, PhD; Bernardo Sopeña, MD, PhD; Jorge Cameselle, MD, PhD; Mercedes Butrón, MD; Manuel Crespo, MD; Antonio Ocampo, MD

Arch Otolaryngol Head Neck Surg. 2000;126:89-92.

A case of severe, oral, not otherwise specified ulcers in a human immunodeficiency virus–infected patient is described. The lesions did not respond to acyclovir, prednisone, pentoxifylline, or foscarnet sodium therapy. Dramatic clinical improvement and progressive ulcer healing were observed after starting oral thalidomide therapy. Clinicians should be aware of the usefulness of thalidomide for the treatment of acquired immunodeficiency syndrome–associated not otherwise specified ulcerations.

From the Special Needs Unit, School of Medicine and Dentistry, Santiago de Compostela University, Santiago de Compostela (Dr Diz Dios), and the Section of Infectious Diseases, Department of Internal Medicine (Drs Sopeña, Crespo, and Ocampo), and Department of Pathology (Drs Cameselle and Butrón), Xeral-Cíes Hospital, Vigo, Spain.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thalidomide: Dual benefits in palliative medicine and oncology
Davis and Dickerson
AM J HOSP PALLIAT CARE 2001;18:347-351.
ABSTRACT